The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer

Breast Cancer Research and Treatment

Volumn 118, Issue 2, 2009, Pages 369-375

  Wu, Meng Fen ^a   Hilsenbeck, S G ^a   Tham, Yee L ^a   Kramer, Rita ^b   Elledge, R M ^a   Chang, J C ^a   Friedman, L C ^c,d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d Ireland Cancer Center   (United States)

Author keywords

Breast cancer; Hormone replacement therapy; Hot flashes; Selective serotonin reuptake inhibitor; Sertraline; Zoloft

Indexed keywords

PLACEBO; SERTRALINE;

ADULT; ANOREXIA; ARTICLE; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; EMOTION; FATIGUE; FEMALE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTION; SIDE EFFECT; SINGLE BLIND PROCEDURE; SLEEP; STATISTICAL SIGNIFICANCE; SWEATING; TREATMENT DURATION; WELLBEING; XEROSTOMIA;

BREAST NEOPLASMS; DOUBLE-BLIND METHOD; FEMALE; HOT FLASHES; HUMANS; MIDDLE AGED; QUALITY OF LIFE; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 70350214276     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0425-y     Document Type: Article

References (23)

1. V Beral 2003 Breast cancer and hormone-replacement therapy in the million women study Lancet 362 9382 419 427 10.1016/S0140-6736(03)14065-2 10.1016/S0140-6736(03)14065-2 1:CAS:528:DC%2BD3sXmt1ajsrw%3D 12927427 (Pubitemid 36999703)
2. TL Bush M Whiteman JA Flaws 2001 Hormone replacement therapy and breast cancer: a qualitative review Obstet Gynecol 98 3 498 508 10.1016/S0029-7844(01) 01453-3 10.1016/S0029-7844(01)01453-3 1:CAS:528:DC%2BD3MXmt1yhsLY%3D 11530137 (Pubitemid 32889588)
3. CL Chen, et al. 2002 Hormone replacement therapy in relation to breast cancer JAMA 287 6 734 741 10.1001/jama.287.6.734 10.1001/jama.287.6.734 1:CAS:528:DC%2BD38Xht1Kktrg%3D 11851540
4. JM Dixon 2001 Hormone replacement therapy and the breast BMJ 323 7326 1381 1382 10.1136/bmj.323.7326.1381 10.1136/bmj.323.7326.1381 1:STN:280:DC%2BD3MnpslKksA%3D%3D 11744551
5. JE Rossouw, et al. 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial JAMA 288 3 321 333 10.1001/jama.288.3.321 10.1001/jama.288.3.321 1:CAS:528:DC%2BD38Xltlegs7k%3D 12117397
6. CL Loprinzi, et al. 1998 Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors J Clin Oncol 16 7 2377 2381 1:CAS:528:DyaK1cXks1Gntb8%3D 9667254
7. CL Loprinzi, et al. 2000 Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial Lancet 356 9247 2059 2063 10.1016/S0140-6736(00)03403-6 10.1016/S0140-6736(00)03403-6 1:CAS:528:DC%2BD3MXnvFSi 11145492 (Pubitemid 32009821)
8. D Barton, et al. 2002 Venlafaxine for the control of hot flashes: results of a longitudinal continuation study Oncol Nurs Forum 29 1 33 40 10.1188/02.ONF.33-40 10.1188/02.ONF.33-40 11817491
9. JS Carpenter, et al. 2007 Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer Oncologist 12 1 124 135 10.1634/theoncologist.12-1-124 10.1634/theoncologist.12-1-124 1:CAS:528:DC%2BD2sXhvVaksrY%3D 17227907 (Pubitemid 46150798)
10. CL Loprinzi, et al. 2002 Phase III evaluation of fluoxetine for treatment of hot flashes J Clin Oncol 20 6 1578 1583 10.1200/JCO.20.6.1578 10.1200/JCO.20.6.1578 1:CAS:528:DC%2BD38XivFeitrs%3D 11896107 (Pubitemid 34260538)
11. V Stearns, et al. 2000 A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors Ann Oncol 11 1 17 22 10.1023/A:1008382706068 10.1023/A:1008382706068 1:STN:280:DC%2BD3c7lsV2ksA%3D%3D 10690382 (Pubitemid 30084574)
12. GG Kimmick, et al. 2006 Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen Breast J 12 2 114 122 10.1111/j.1075-122X.2006.00218.x 10.1111/j.1075-122X.2006.00218.x 16509835
13. PR Gordon, et al. 2006 Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population Menopause 13 4 568 575 10.1097/01.gme.0000196595.82452.ca 10.1097/01.gme.0000196595.82452.ca 16837878 (Pubitemid 44079527)
14. Cella DF (1997) Manual of the functional assessment of chronic illness therapy (FACIT) scales. Version 4. Center on outcomes, research and education (CORE), Evanston Northwestern Healthcare and Northwestern University, Evanston IL
15. JP Kerwin PR Gordon JH Senf 2007 The variable response of women with menopausal hot flashes when treated with sertraline Menopause 14 5 841 845 10.1097/gme.0b013e31802e7f22 10.1097/gme.0b013e31802e7f22 17413648 (Pubitemid 47517581)
16. D Grady, et al. 2007 Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial Obstet Gynecol 109 4 823 830 1:CAS:528:DC%2BD2sXkvVOls74%3D 17400842
17. S Borges, et al. 2006 Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment Clin Pharmacol Ther 80 1 61 74 10.1016/j.clpt.2006.03.013 10.1016/j.clpt.2006.03.013 1:CAS:528:DC%2BD28Xms1enu7k%3D 16815318 (Pubitemid 43946844)
18. V Stearns, et al. 2003 Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine J Natl Cancer Inst 95 23 1758 1764 1:CAS:528: DC%2BD3sXpvVelsbc%3D 14652237
19. Y Jin, et al. 2005 CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment J Natl Cancer Inst 97 1 30 39 1:CAS:528:DC%2BD2MXisVaqsw%3D%3D 15632378
20. MP Goetz, et al. 2007 The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen Breast Cancer Res Treat 101 1 113 121 10.1007/s10549-006-9428-0 10.1007/s10549-006-9428-0 1:CAS:528: DC%2BD2sXisVylsg%3D%3D 17115111 (Pubitemid 47555336)
21. Piantadosi S (2005) Clinical trials: a methodological perspective, 2nd edn. Wiley, New York
22. SK Quella, et al. 1999 Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer J Urol 162 1 98 102 10.1097/00005392-199907000-00024 10.1097/00005392-199907000- 00024 1:CAS:528:DyaK1MXktFenu74%3D 10379749 (Pubitemid 29420889)
23. JA Sloan, et al. 2001 Methodologic lessons learned from hot flash studies J Clin Oncol 19 23 4280 4290 1:STN:280:DC%2BD3MnosFWgtA%3D%3D 11731510